
|Articles|December 1, 2015
- Applied Clinical Trials-05-01-2013
- Volume 22
- Issue 5
Applied Clinical Trials Digital Edition - May 2013
Subject Recruitment: The Ideas Initiative Trial Design: Early Phase CNS Drug Liabilities; Improving Enrollment Forecasts Also in this issue: Update on Europe's Clinical Trial Rules Debate Public Perception of Clinical Research Clinical Trial Barriers
Advertisement
Articles in this issue
over 12 years ago
The IDEAS Initiativeover 12 years ago
Sponsors and Service Providers Share Their Experiencesover 12 years ago
Optimizing Efficiencyover 12 years ago
Principal Investigators Take the Lead FDA-Regulated Studiesover 12 years ago
Improving Clinical Trial Enrollment Forecasts Using SORMover 12 years ago
Breaking Down Clinical Barriersover 12 years ago
ACT Coverover 12 years ago
CNS Drug Liabilities in Early Phase Clinical TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal
2
Securing Comparator Drugs in Competitive EU Markets: Challenges and Practical Solutions
3
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
4
ACT Brief: Rethinking Representation in Cancer Trials, Positive Phase IIb SLE Data, and a Major Obesity Drug Partnership
5




